SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Growth Hormone Deficiency.

"In people with progressive cognitive decline, the diagnosis of Alzheimer's disease requires a demonstration of amyloid and ...

Hormones do a lot throughout a person’s lifespan. Most people associate hormones with development and sex. Learn about their ...

FDA approves Crenessity a groundbreaking drug for classic congenital adrenal hyperplasia CAH reducing steroid use and offering new hope for patients with this rare disorder ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

“Growth hormone therapy typically requires daily ... Our approved products in Japan include therapies for the treatment of growth disorder, MPS II (Hunter syndrome), Fabry disease, acute graft ...

Bipolar I disorder is a mental health condition that causes extreme ups and downs in mood and energy. You might hear it called “manic-depressive disorder” or “manic depression,” which are ...

(NASDAQ:IRON), a biotechnology company with a market capitalization of $1.93 billion focused on developing treatments for rare blood disorders, has been garnering attention from analysts ... This ...

They try to follow a diet but fail most of the time. The causes of eating disorders are hormone Imbalance, passion for being fit, stress, depression, TB, diabetes and smoking too much.